chr7-94663718-T-A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The ENST00000612748.1(PEG10):​c.390T>A​(p.Asp130Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,611,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000060 ( 0 hom. )

Consequence

PEG10
ENST00000612748.1 missense

Scores

18

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -4.29

Publications

2 publications found
Variant links:
Genes affected
PEG10 (HGNC:14005): (paternally expressed 10) This is a paternally expressed imprinted gene that is thought to have been derived from the Ty3/Gypsy family of retrotransposons. It contains two overlapping open reading frames, RF1 and RF2, and expresses two proteins: a shorter, gag-like protein (with a CCHC-type zinc finger domain) from RF1; and a longer, gag/pol-like fusion protein (with an additional aspartic protease motif) from RF1/RF2 by -1 translational frameshifting (-1 FS). While -1 FS has been observed in RNA viruses and transposons in both prokaryotes and eukaryotes, this gene represents the first example of -1 FS in a eukaryotic cellular gene. This gene is highly conserved across mammalian species and retains the heptanucleotide (GGGAAAC) and pseudoknot elements required for -1 FS. It is expressed in adult and embryonic tissues (most notably in placenta) and reported to have a role in cell proliferation, differentiation and apoptosis. Overexpression of this gene has been associated with several malignancies, such as hepatocellular carcinoma and B-cell lymphocytic leukemia. Knockout mice lacking this gene showed early embryonic lethality with placental defects, indicating the importance of this gene in embryonic development. Additional isoforms resulting from alternatively spliced transcript variants, and use of upstream non-AUG (CUG) start codon have been reported for this gene. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041588545).
BP6
Variant 7-94663718-T-A is Benign according to our data. Variant chr7-94663718-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 3211335.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 106 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEG10NM_001172437.2 linkc.390T>A p.Asp130Glu missense_variant Exon 2 of 2 NP_001165908.1 Q86TG7-4
PEG10NM_001184961.1 linkc.264T>A p.Asp88Glu missense_variant Exon 2 of 2 NP_001171890.1 Q86TG7
PEG10NM_015068.3 linkc.162T>A p.Asp54Glu missense_variant Exon 2 of 2 NP_055883.2 Q86TG7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEG10ENST00000612748.1 linkc.390T>A p.Asp130Glu missense_variant Exon 2 of 3 5 ENSP00000480676.1 A0A087WX23

Frequencies

GnomAD3 genomes
AF:
0.000658
AC:
100
AN:
151988
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00235
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000156
AC:
38
AN:
243624
AF XY:
0.000129
show subpopulations
Gnomad AFR exome
AF:
0.00247
Gnomad AMR exome
AF:
0.0000294
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000908
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000603
AC:
88
AN:
1459376
Hom.:
0
Cov.:
35
AF XY:
0.0000648
AC XY:
47
AN XY:
725670
show subpopulations
African (AFR)
AF:
0.00200
AC:
67
AN:
33430
American (AMR)
AF:
0.000113
AC:
5
AN:
44416
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26074
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39628
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53198
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1110862
Other (OTH)
AF:
0.000199
AC:
12
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000697
AC:
106
AN:
152106
Hom.:
0
Cov.:
32
AF XY:
0.000780
AC XY:
58
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.00248
AC:
103
AN:
41486
American (AMR)
AF:
0.000196
AC:
3
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000629
Hom.:
0
Bravo
AF:
0.000737
ESP6500AA
AF:
0.00263
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000198
AC:
24
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 14, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.0010
DANN
Benign
0.18
DEOGEN2
Benign
0.015
.;T;.;T;T;T
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.4
FATHMM_MKL
Benign
0.015
N
LIST_S2
Benign
0.51
T;T;T;T;T;T
M_CAP
Benign
0.0014
T
MetaRNN
Benign
0.0042
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.41
N;.;.;.;.;.
PhyloP100
-4.3
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.30
N;.;.;.;.;.
REVEL
Benign
0.0040
Sift
Benign
0.65
T;.;.;.;.;.
Sift4G
Benign
1.0
T;T;T;T;T;T
Polyphen
0.0
.;B;.;.;.;.
Vest4
0.049
MutPred
0.31
Gain of loop (P = 0.0321);.;.;Gain of loop (P = 0.0321);.;.;
MVP
0.068
MPC
0.70
ClinPred
0.015
T
GERP RS
-8.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.14
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200610645; hg19: chr7-94293030; API